Thyroid Gland Disorders Treatment Market in Asia Pacific Expected to Grow at Highest Cagr of 3.6% in Future

Submitted by: Submitted by

Views: 10

Words: 592

Pages: 3

Category: Business and Industry

Date Submitted: 05/12/2016 02:14 AM

Report This Essay

According to a new market research report published by Transparency Market Research “Thyroid Gland Disorders Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023” the global thyroid gland disorders treatment market was valued at US$1.8 bn in 2014 and is estimated to reach a market value of US$2.4 bn in 2023 expanding at a CAGR of 3.1% from 2015 to 2023.

Download Report Brochure,Get Details Industry Insights:http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3113

Thyroid gland disorder is characterized by underactive or overactive production of thyroid hormones (T3 and T4), termed as hypothyroidism or hyperthyroidism respectively. Globally, the thyroid gland disorders treatment market is expanding at a promising growth rate owing to the rising prevalence of thyroid gland disorders and growing preference for thyroid therapeutics in developed as well as developing regions. Moreover, growing geriatric population and consistent efforts of key companies to develop novel therapeutics would also account for the growth of the thyroid gland disorders treatment market. However, dominance of generic formulations coupled with availability of reliable alternative treatment therapies such as herbal medicine could hamper the market growth in the near future. The global thyroid gland disorders treatment market was valued at US$1,806.2 mn in 2014 and is expected to reach US$2,414.6 mn by 2023, expanding at a CAGR of 3.1% from 2015 to 2023.

Geographically, North America was the largest market for thyroid gland disorders treatment market in 2014. Increasing prevalence of thyroid disorders would primarily accentuates the thyroid gland disorders treatment market growth in the region. For instance, a study conducted by the National Health and Nutrition Examination Survey in July 2012 evaluated that the prevalence of hypothyroidism varies from 4.6% to 9.5% of the U.S. population every year. However, preference of...